Children with severe combined immunodeficiency (SCID) have profoundly diminished humoral and cellular immunity resulting in death during infancy unless immune reconstitution occurs by bone marrow transplantation (BMT). Thrombocytopenia post-bone marrow transplantation can be seen in relation to infection, graft-versus-host disease (GVHD) and rarely, as an autoimmune phenomenon due to immune dysregulation. We report two cases of severe AITP following BMT for SCID. Both cases developed large intracerebral hemorrhages from which one died. Autoimmune thrombocytopenia in this setting can be life-threatening and we recommend early and active intervention. Keywords: autoimmune thrombocytopenia; BMT; severe combined immunodeficiency Severe combined immunodeficiency (SCID) is a syndrome describing children with profound cellular and humoral immune dysfunction attributable to different causes such as enzyme deficiencies (ADA, PNP), 1,2 T cell defects, defective HLA expression, as well as the more common ␥c deficiency.
Severe combined immunodeficiency (SCID) is a syndrome describing children with profound cellular and humoral immune dysfunction attributable to different causes such as enzyme deficiencies (ADA, PNP), 1, 2 T cell defects, defective HLA expression, as well as the more common ␥c deficiency. 3 For these patients, with the exception of ADA deficiency, bone marrow transplantation (BMT) is the therapy of choice. 4, 5 The time taken for engraftment of the marrow cells and immune reconstitution varies depending on multiple factors. These include: (a) the use of T cell depleted [6] [7] [8] vs unfractionated bone marrow cells; 9, 10 (b) pre-transplant conditioning; (c) the presence or absence of graft-versushost disease (GVHD) and its treatment; 11 (d) concomitant infections; and (e) the general status of the patient. 12 During this early post-transplant period, the immune imbalance observed as the donor immune system emerges, modified by the host, results in well described symptom complexes such as GVHD. 11, [13] [14] [15] [16] This underlying immune dysregulation may also result in autoimmune cytopenias. 12, 17 We report two cases of severe AITP following a haploidentical, T cell-depleted allogeneic BMT for SCID. /l. Response to mitogen was not performed due to the almost absent number of T cells. She underwent a T cell-depleted (soybean lectin sheep E-rosetting), haploidentical BMT without conditioning from her father at 4 months of age. Engraftment was documented on day +21 post-transplant by fluorescent in situ hybridization (FISH) studies for XY cells and the post-transplantation course was complicated by respiratory failure, acute renal failure and graft-versus-host disease (GVHD) involving skin and gastrointestinal tract treated with weaning doses of prednisone (2 mg/kg/day). She also had evidence of hyperproduction of IgM and Bence-Jones proteinuria confirmed by electrophoretogram (EPG) and immuno-electrophoretogram (IEPG) and tests for Epstein-Barr virus were negative. She was discharged at 2 months post-transplant still lymphopenic and mildly thrombocytopenic although asymptomatic, with Hb 7.5 g/dl, WCC 4.0 × 10 9 /l and plat 87 × 10 9 /l. At 5. months post-transplant, she was admitted with increasing petechiae with no clinical manifestations of infection or GVHD and her T cell function assessed by PHA a week previously had a reduced reponse. Admission platelet count was 7 × 10 9 /l, Hb was 9.9 g/dl and WCC was 4.4 × 10 9 /l. Coagulation studies were normal with international normalised ratio (INR) 1.2 (0.9-1.1) and activated partial thromboplastin time (APTT) 35s (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Cultures of blood and urine, in particular, viral cultures and antigen for adenovirus from stools were negative. Bone marrow examination showed increased cellularity with megakaryocytic hyperplasia. IgG platelet-specific antibody to an antigen located on the Ib/IX glycoprotein, an autoantibody, was isolated from the patient and not found in the donor who had a normal platelet count of 341 × 10 9 /l at the time. The thrombocytopenia progressed rapidly with trough platelet levels reaching 1 × 10 9 /l. Despite platelet infusions, methyl prednisolone (4 mg/kg stat, then 2 mg/kg/day up to 15 mg/kg/day) and intravenous immunoglobulin (IVIG) 2 g/kg, her severe thrombocytopenia persisted with worsening bleeding. A splenectomy was therefore undertaken.
Post-splenectomy, on that same day, her platelet count post-operation remained low at 3 × 10 9 /l and she had a left occipitoparietal hemorrhage confirmed on CT scan. She died the same day. Autopsy revealed a left-sided intracerebral hemorrhage with associated subdural and subarachnoid hemorrhages.
Patient B
The second case, also female, was diagnosed with T − B + SCID (normal ADA and PNP levels) at 3 months of age following recurrent respiratory and persistent skin infections. Her laboratory data included: Hb 10.1 g/dl, WCC 11.5 × 10 9 /l, plat 695 × 10 9 /l, Ig G/A/M of 1.1/Ͻ0.07/0.06 g/l, and CD3 0.175, CD4 0.056, CD8 0.056, CD19 0.224 and NK cells 2.46 × 10 9 /l. Response to mitogens was absent. A T-cell-depleted (soybean lectin sheep E-rosetting), haploidentical maternal BMT was undertaken with thiotepa 5 mg/kg × 3 days, cyclophosphamide 50 mg/kg × 4 days, and ATG (anti-thymocyte globulin) 12 mg/kg × 3 days for immunosuppression prior to transplantation. Hematological engraftment occurred by day +10 and donor maternal haplotype was confirmed 3. months after BMT. She developed mild cutaneous grade 1 GVHD treated with prednisone 1 mg/kg/day. Full blood count at 2 months post-transplant showed a WCC of 5.7 × 10 9 /l, Hb 9.0 g/dl, and platelet count of 330 × 10 9 /l and her T cell function remained suboptimal with a reduced PHA response.
Thrombocytopenia developed at 2. months. Bone marrow aspirate revealed a normal marrow with plentiful megakaryocytes, consistent with an autoimmune thrombocytopenia. Treatment with prednisone 2 mg/kg/day and IVIG 2 g/kg failed to effect any sustained response. She was readmitted following a history of increasing bruising and signs of increased intracranial pressure with an admission WCC of 5.2 × 10 9 /l, Hb 12.7 g/dl and plat of 2 × 10 9 /l and coagulation studies showed INR 1.1, APTT with polybrene of 47.1 s and fibrinogen of 4.02. She developed seizures shortly after admission and cerebral CT scan revealed intraventricular hemorrhage with extension into the frontal horns, right intracerebral region and right parietal area with multiple small petechiae. This was associated with significant cerebral edema and shift which necessitated the use of high-dose steroids (dexamethasone 0.5 mg/kg every 6 h) intravenously. Her platelet count responded on this occasion and remained stable even after weaning off the steroid. Her last platelet count (at 1 month follow-up) was 330 × 10 9 /l and she has remained on anticonvulsant therapy. There was no evidence of overt neurological deficit although long-term follow-up will be necessary to assess her progress, in particular, her cognitive development.
Discussion
Thrombocytopenia after BMT can occur with infections, GVHD 13 and rarely, as an autoimmune phenomenon 12, 17 thought to occur because of immune dysregulation as seen in autoimmune disorders 15, 16 and in primary immunodeficiency. We have reported two cases of severe thrombocytopenia following BMT, most likely autoimmune in nature.
Firstly, bone marrow aspirates in both children were normal to hypercellular with plentiful megakaryocytes. In addition, there were no clinical indications, including an extensive septic work-up, of any infections. In relation to GVHD, at the time of presentation with their thrombocytopenia, neither patient had features suggestive of GVHD. Mild GVHD in both patients seen during the early post-BMT period had settled with weaning doses of prednisone. Thrombocytopenia seen in the setting of GVHD has been most impressive in chronic GVHD. 13 Patient A had a platetlet specific IgG antibody directed against GpIb/IX not present in either parent, indicating that the antibody was not derived passively from the transfusion of the father's plasma to the patient. Due to the degree of her thrombocytopenia, immunoglobulin specific for her platelets could not be tested. Other evidence of immune dysregulation in patient A was her hyperproduction of Ig M and Bence-Jones proteinuria, EBV having been exlcuded as the provoking cause. There have been only a few cases of autoimmune thrombocytopenia reported after BMT, all of which were in adults. 12, [17] [18] [19] There are no reports of similar cases in children. Both patients also had large intracerebral hemorrhages not described in the adult cases. We wonder if children are at higher risk of intracerebral bleeding. A relatively high incidence of autoimmune hemolytic anemia associated with a high mortality rate has recently been reported after T cell-depleted allogeneic BMT with implications of defective T cell function. 20 Although rare, autoimmune pancytopenia has also recently been described in two patients undergoing total lymphoid irradiation (TLI) due to failure to respond to conventional immunosuppressive therapy and splenectomy. 21, 22 Patient B only responded to the high-dose dexamethasone which was initiated for the cerebral edema at the peak of her thrombocytopenia during her intracerebral bleed. Although TLI was not used in our patients due to the rapid deterioration in patient A and the rapid sustained response to high-dose steroid in patient B, its early use would be worth considering if conventional measures fail to achieve a prompt response.
In view of the severity of this condition, we would strongly recommend early and aggressive therapy for AITP with a higher steroid dosage (dexamethasone 0.5 mg/kg q6 h), bearing in mind, of course, its adverse effect on immune recovery and risk of infection.
